{"id":"W2987001203","doi":"10.1093/neuonc/noz175.056","title":"ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal; McGill University; University of Calgary","funders":"","keywords":"Procarbazine; Medicine; Lomustine; Oligodendroglial Tumor; Internal medicine; Hazard ratio; Oncology; Anaplastic astrocytoma; Oligodendroglioma; Vincristine; Progression-free survival; Chemoradiotherapy; Proportional hazards model; Nuclear medicine; Glioma; Radiation therapy; Astrocytoma; Overall survival; Chemotherapy; Confidence interval; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00167973,0.0004528892,0.001057912,0.0003337694,0.0002578552,0.0005516799,0.00062127,0.0005631056,0.01675677],"category_scores_gemma":[0.0009439511,0.0002225443,0.001271145,0.0003085818,0.0002365164,0.0001806078,0.0003478717,0.001208713,0.003294573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009738968,"about_ca_system_score_gemma":0.001632734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002518343,"about_ca_topic_score_gemma":0.00752598,"domain_scores_codex":[0.9993703,0.000325427,0.00004139847,0.00009816203,0.00008570823,0.00007917921],"domain_scores_gemma":[0.9993304,0.0001168395,0.0001084555,0.00006939172,0.00006186146,0.0003131719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5709065,0.01146617,0.01248528,0.001151951,0.001565879,0.0002098432,0.00008419315,0.002320748,0.01847042,0.0005410775,0.05077214,0.330026],"study_design_scores_gemma":[0.3979601,0.3018453,0.1490309,0.0006121965,0.00462542,0.0009495729,0.00009115687,0.003775662,0.01434261,0.0009819114,0.1257152,0.00007006445],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8695128,0.01271204,0.002034549,0.004129612,0.00108844,0.01050238,0.03789699,0.0007661719,0.06135696],"genre_scores_gemma":[0.9017811,0.003863881,0.007463874,0.003754213,0.0005050697,0.007133185,0.02952408,0.0003724776,0.0456021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01675677,"threshold_uncertainty_score":0.05605698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0254265101341337,"score_gpt":0.3021182422471342,"score_spread":0.2766917321130005,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}